Literature DB >> 264681

Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line.

T Boon, O Kellermann.   

Abstract

Cells from the malignant teratocarcinoma line PCC4.azal were treated with the mutagen N-methyl-N'-nitro-N-nitrosoguanidine. Fifty-five clones were isolated from the surviving cells. Twelve clones are unable to form tumors in the syngeneic 129/Sv mice. However, these "tum-" clones form tumors as readily as the original cells when they are injected into irradiated mice. Moreover, they stimulate the production of immune memory cells, which protect the injected animals and confer resistance by adoptive transfer. The tum- clones are therefore unable to generate tumors in syngeneic mice because they elicit an immune rejection response.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 264681      PMCID: PMC393241          DOI: 10.1073/pnas.74.1.272

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  LYMPHOCYTE INTERACTION: A POTENTIAL HISTOCOMPATIBILITY TEST IN VITRO.

Authors:  F BACH; K HIRSCHHORN
Journal:  Science       Date:  1964-02-21       Impact factor: 47.728

2.  MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.

Authors:  L J KLEINSMITH; G B PIERCE
Journal:  Cancer Res       Date:  1964-10       Impact factor: 12.701

3.  The histophysiology of the antibody response. II. Antibody responses and splenic plasma cell reaction in sublethally x-irradiated rabbits.

Authors:  F J KEUNING; P NIEUWENHUIS; P OUDENDIJK
Journal:  Lab Invest       Date:  1963-02       Impact factor: 5.662

4.  In vitro cell migration as a model for delayed hypersensitivity.

Authors:  M GEORGE; J H VAUGHAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

5.  Studies on transplantable testicular teratomas of strain 129 mice.

Authors:  L C STEVENS
Journal:  J Natl Cancer Inst       Date:  1958-06       Impact factor: 13.506

6.  Cell-mediated antitumor immune reactions under syngeneic conditions.

Authors:  J C Leclerc; A Senik; E Gomard; F Plata; J P Levy
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

7.  The isolation and properties of a clonal tissue culture strain of pluripotent mouse teratoma cells.

Authors:  M J Evans
Journal:  J Embryol Exp Morphol       Date:  1972-08

8.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

9.  The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos.

Authors:  L C Stevens
Journal:  Dev Biol       Date:  1970-03       Impact factor: 3.582

10.  Developmental potentialities of clonal in vitro cultures of mouse testicular teratoma.

Authors:  B W Kahan; B Ephrussi
Journal:  J Natl Cancer Inst       Date:  1970-05       Impact factor: 13.506

View more
  52 in total

1.  Mapping of the genes encoding tum- transplantation antigens P91A, P35B, and P198.

Authors:  P J Dyson; C de Smet; A M Knight; D Simon-Chazottes; J L Guénet; T Boon
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 2.  Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Authors:  Pierre G Coulie; Benoît J Van den Eynde; Pierre van der Bruggen; Thierry Boon
Journal:  Nat Rev Cancer       Date:  2014-02       Impact factor: 60.716

3.  Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay.

Authors:  T Wölfel; A Van Pel; E De Plaen; C Lurquin; J L Maryanski; T Boon
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

4.  T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis.

Authors:  T Boon; A Van Pel
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

Review 5.  Immunotherapy and radiation in glioblastoma.

Authors:  Solmaz Sahebjam; Andrew Sharabi; Michael Lim; Pravin Kesarwani; Prakash Chinnaiyan
Journal:  J Neurooncol       Date:  2017-05-31       Impact factor: 4.130

6.  Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens.

Authors:  P Fuschiotti; M C Fioretti; L Romani; P Puccetti
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 7.  Tools to define the melanoma-associated immunopeptidome.

Authors:  Eva Bräunlein; Angela M Krackhardt
Journal:  Immunology       Date:  2017-08-28       Impact factor: 7.397

8.  Decreased tumorigenicity correlates with expression of altered cell surface carbohydrates in Lec9 CHO cells.

Authors:  J Ripka; S Shin; P Stanley
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

9.  Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice.

Authors:  A Van Pel; M Georlette; T Boon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

Review 10.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.